![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Novacyt S.a. | LSE:NCYT | London | Ordinary Share | FR0010397232 | EUR1/15TH (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.70 | 3.59% | 49.00 | 47.40 | 49.00 | 48.70 | 45.60 | 48.00 | 169,794 | 16:35:10 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
In Vitro,in Vivo Diagnostics | 11.58M | -28.29M | - | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
04/3/2020 07:57 | From fridays rns PHE as part of its planning has also invited diagnostic manufacturers (including Primerdesign) to submit tests for a formal evaluation process, which is expected to conclude next month. It is not known at this time what conclusions or guidance the PHE will subsequently give to the NHS for COVID-19 testing.Now next month | mcrudden | |
04/3/2020 07:57 | This is about to go down the rabbit hole and come out at 45p. !!! | the white rabbit | |
04/3/2020 07:56 | Should tank now | ![]() datait | |
04/3/2020 07:33 | I see 100-105 finish for today | ![]() iamgreat1 | |
04/3/2020 07:33 | These kits are going to viral sell, for an example of this just look at sales and availability of hand sanitizers and digital thermometers, not one shop in my town has either. | ![]() 7rademark | |
04/3/2020 07:25 | Morning Chief,All these guys have been up all night scare mongering, real investors have been sleeping.If you read the RNS, we have nothing to worry about, FDA approval or not. The FDA won't just give an approval out willy nilly the need to test and analyse numbers. We can sell and supply our product globally without approval. Unfortunately CV is not going anywhere.If you look at the website and distributers on our websites they distributors are growing daily, the company are advertising for roles etc. We have much more news on the way than FDA approval. CDFA approval. USA OEM update. This stock in volatile. Also global sales for cats and update. The shorts want their money. It will go up and down like it has done for the last 3 weeks until solid FDA approval. Many companies including one that just been bought (Qiagen) out are still awaiting approval from the FDAHang tight and do t worry. | adamfletcher1 | |
04/3/2020 07:20 | Paris, France and Camberley, UK - 28 February 2020 - Novacyt ( EURONEXT GROWTH: ALNOV; AIM: NCYT ), an international specialist in clinical diagnostics, is pleased to provide an update regarding the novel coronavirus (COVID-19) test developed by Primerdesign, its molecular diagnostics division, and announces it has signed a major distribution agreement in Asia and an original equipment manufacturer (OEM) agreement with a US healthcare group .As of 27 February 2020, Primerdesign has sold over GBP0.93m (EUR1.1m) of CE-Mark and research use only (RUO) tests. Since launching its CE-Mark test, the Company is experiencing high levels of interest in its product. The value of quotations has grown significantly as Novacyt is currently involved in active discussions with representatives from a number of countries which have an acute need for tests as part of their national screening programmes. D ue to the high level of interest in the Primerdesign COVID-19 test and rapidly evolving nature of this outbreak, the Company cannot predict with any certainty the conversion rate of these ongoing enquiries into orders.Primerdesign has also signed its first major distribution agreement for the COVID-19 test with a global life sciences company to supply the test to two Asian territories outside mainland China. Initial sales, which are subject to local emergency use approval, are anticipated to be GBP2.1m (EUR2.5m) during the first six months of the agreement. It is expected that the first sales under this agreement will take place in March 2020.The Company also announces that it has signed an OEM agreement with a US healthcare group for the manufacture and sale of its RUO coronavirus tests.In addition, as previously announced, the Primerdesign test is currently under review by the US Food and Drug Administration (FDA) for Emergency Use Approval, which would allow the test to be used for clinical diagnosis of COVID-19 in the US. The FDA and the Company are in regular contact.Public health authorities around the world are pursuing a variety of strategies when it comes to testing for COVID-19. For example, Public Health England (PHE) has issued testing guidance to the NHS to be deployed across eight testing centres in the UK. PHE as part of its planning has also invited diagnostic manufacturers (including Primerdesign) to submit tests for a formal evaluation process, which is expected to conclude next month. It is not known at this time what conclusions or guidance the PHE will subsequently give to the NHS for COVID-19 testing.The current COVID-19 screening procedure in France involves directing all patient samples to the Institut Pasteur in Paris. It is not known at this time whether more widespread testing will be performed and what test methods will be approved for use in these hospitals and clinics.Other health authorities around the world have approved tests for emergency use from local manufacturers and many are also currently reviewing the Primerdesign test. The speed and processes to gain emergency approval for tests differs from country-to-country depending on their approval process and the perceived threat level of COVID-19.The Company has put in place a number of measures to significantly increase production capacity and continues to plan for greater throughput to ensure Primerdesign can meet all current and potential demand. These measures include, if necessary, using the Company's manufacturing capacity at both its UK sites. | mcrudden | |
04/3/2020 06:51 | The problem is that there are already suppliers of kits out there. The FDA in America are even relaxing rules to allow more labs to carry out their own tests.One example is Randox who are currently supplying test kits so even if approval is given here it is only a matter of weeks before multiple suppliers are chomping at the bit to get the sales - these kits are from being a one trick pony.https://www.goo | ![]() supercity | |
04/3/2020 06:50 | Looks like another drug company have a cure 10 positives tested on the coronavirus. I think this will tank from here. | ![]() datait | |
03/3/2020 23:35 | If you mean decent investors Andy then I wouldn't worry those who have researched will hold and those who trade will come back...but I and I'm sure others have better things to do than post here every 5 minutes even though i quite enjoy reading your posts...they do make me laugh. Sleep well, early start tomorrow | mcrudden | |
03/3/2020 23:26 | Chief Vigilante3 Mar '20 - 22:50 - 6221 of 6224 0 2 1 All the rampers have stopped posting. Did they leave Chief holding the baby alone, again? ——— TheyBeen munchedBy whiteShark | ![]() andymunchkin | |
03/3/2020 22:50 | Only one weirdo posting on here, then again a few tbf. | ![]() jamie414 | |
03/3/2020 22:43 | Flash crash on dow today. Hope no flash crash on ncyt. :( | flash crash | |
03/3/2020 22:37 | Iconcur ----------- feds strategyFailed buyersOrders missing theMarket keptOn goingDown &Down | ![]() andymunchkin | |
03/3/2020 22:35 | Some posters on here are an absolute disgrace.They should be ashamed of themselves. | ![]() jamie414 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions